In this @-week , randomized , open-label , multinational , treat-to-target trial , participants ( mean age @ years , duration of diabetes @ years , BMI @ kg/m ( @ ) , and HbA@c @ % -LSB- @ mmol/mol -RSB- ) were exposed ( @:@ ) to BID injections of IDegAsp ( n = @ ) or BIAsp @ ( n = @ ) , administered with breakfast and the main evening meal and dose titrated to a self-measured premeal plasma glucose ( PG ) target of @-@ @ mmol/L .